Astrazeneca Treasury Limited
Company 02910116 Active
Connected board network
The connection graph needs a free account.
This company's record is public. The network of who else its directors govern is compiled from the registers by us, and an account keeps it out of bulk scrapers.
Sign in, freeBoard DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
3 directors on the board
- Matthew Shaun Bowden Director · appointed 2019
- Jonathan Thomas Charles Slade Director · appointed 2018
- Iain Alistair Collins Director · appointed 2017
8.2y median 8.1y
average tenure
9.1y
longest tenure
Directors past 6 years
- Matthew Shaun Bowden Director · appointed 2019
- Jonathan Thomas Charles Slade Director · appointed 2018
- Iain Alistair Collins Director · appointed 2017
First-time vs portfolio directors
Portfolio (3)
- Matthew Shaun Bowden Director · appointed 2019
- Jonathan Thomas Charles Slade Director · appointed 2018
- Iain Alistair Collins Director · appointed 2017
0
also govern a charity
0
left in the last 12 months
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
Professional services 16Business services 14Finance 2Manufacturing 2
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Several long-serving directors could step down together
Where to look Suggested search: succession planning for long-tenured seats.
Related organisations iRelated organisationsTwo groups, both deterministic from public records. Related organisations share two or more directors with this board - a real structural link, such as a subsidiary or group company. Connected through a shared director share exactly one person - a genuine connection, but not the same group.
Related organisations
- Astrazeneca Intermediate Holdings Limited 3 shared directors
- Astra Pharmaceuticals Limited 2 shared directors
- Astrapharm 2 shared directors
- Medimmune Limited 2 shared directors
- Astrazeneca Finance Limited 2 shared directors
- Cambridge Antibody Technology Group Limited 2 shared directors
Deterministic, from public records.
Company details
| Number | 02910116 |
| Status | Active |
| Type | Private Limited Company |
| Incorporated | 18/03/1994 |
| Address | 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA |
| Accounts next due | 30/09/2027 |
| Accounts last made up | 31/12/2025 |
Industry (SIC)
70100 - Activities of head offices
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Astrazeneca UK Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06
Owns 12 companies iOwnsCompanies where this company is registered as having significant control, from the Companies House PSC (persons with significant control) register.
- Cambridge Antibody Technology Group Limited
75-100% shares, appoints directors · notified 2016-04-06 - Ardea Biosciences Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 - Astrazeneca Sweden Investments Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 - 09406851
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 - Astrapharm
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 - Azenco4 Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 - Zeneca Finance (Netherlands) Company
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 - Zenco (NO. 8) Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 - 15723678
75-100% shares, 75-100% voting, appoints directors · notified 2024-05-16 - 15725014
75-100% shares, 75-100% voting, appoints directors · notified 2024-05-16 - Medimmune U.K. Limited ceased 2017-01-01
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 - Entasis Therapeutics Limited ceased 2018-04-23
25-50% shares · notified 2016-04-06
Officers (19)
- Camilla Johnstone Secretary · appointed 2025
- Matthew Shaun Bowden Director · appointed 2019
- Jonathan Thomas Charles Slade Director · appointed 2018
- Iain Alistair Collins Director · appointed 2017
Show 15 former officers
- Katie Louise Jackson-Turner Secretary · appointed 2015 · resigned 2019
- Claire-Marie O'Grady Secretary · appointed 2014 · resigned 2015
- Brendan James Boucher Director · appointed 2014 · resigned 2017
- Patricia May Greenfield Director · appointed 2011 · resigned 2014
- Keith Stuart Darlington Director · appointed 2011 · resigned 2014
- Adrian Charles Noel Kemp Director · appointed 2009 · resigned 2025
- Ian Martin David Brimicombe Director · appointed 2006 · resigned 2017
- Sean Lloyd Christie Director · appointed 2006 · resigned 2011
- Adrian Ross Thomas Marsh Director · appointed 2003 · resigned 2006
- John Howard Cole Director · appointed 2000 · resigned 2010
- Jonathan Richard Symonds Director · appointed 2000 · resigned 2007
- Per Alf Gunner Nordberg Director · appointed 2000 · resigned 2002
- Graeme Harold Rankine Musker Secretary · appointed 2000 · resigned 2008
- Jane Fiona Juniper Director · appointed 1994 · resigned 2000
- Cacilia Maria Lachlan Nominee-secretary · appointed 1994 · resigned 2000
Directors and officers on the Companies House record, current and former.
Report an error in this record - let us know.
Related record